136 related articles for article (PubMed ID: 38235848)
1. SARS-CoV-2 NSP12 utilizes various host splicing factors for replication and splicing regulation.
Yang L; Zeng XT; Luo RH; Ren SX; Liang LL; Huang QX; Tang Y; Fan H; Ren HY; Zhang WJ; Zheng YT; Cheng W
J Med Virol; 2024 Jan; 96(1):e29396. PubMed ID: 38235848
[TBL] [Abstract][Full Text] [Related]
2. Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2.
Machitani M; Takei J; Kaneko MK; Ueki S; Ohashi H; Watashi K; Kato Y; Masutomi K
Virol J; 2022 Dec; 19(1):213. PubMed ID: 36496472
[TBL] [Abstract][Full Text] [Related]
3. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
[TBL] [Abstract][Full Text] [Related]
4. Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens.
Sexton NR; Smith EC; Blanc H; Vignuzzi M; Peersen OB; Denison MR
J Virol; 2016 Aug; 90(16):7415-7428. PubMed ID: 27279608
[TBL] [Abstract][Full Text] [Related]
5. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M
J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225
[TBL] [Abstract][Full Text] [Related]
6. The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
Lung J; Lin YS; Yang YH; Chou YL; Shu LH; Cheng YC; Liu HT; Wu CY
J Med Virol; 2020 Jun; 92(6):693-697. PubMed ID: 32167173
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis.
Guo S; Lei X; Chang Y; Zhao J; Wang J; Dong X; Liu Q; Zhang Z; Wang L; Yi D; Ma L; Li Q; Zhang Y; Ding J; Liang C; Li X; Guo F; Wang J; Cen S
Signal Transduct Target Ther; 2022 Dec; 7(1):400. PubMed ID: 36575184
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 variants with NSP12 P323L/G671S mutations display enhanced virus replication in ferret upper airways and higher transmissibility.
Kim SM; Kim EH; Casel MAB; Kim YI; Sun R; Kwak MJ; Yoo JS; Yu M; Yu KM; Jang SG; Rollon R; Choi JH; Gil J; Eun K; Kim H; Ensser A; Hwang J; Song MS; Kim MH; Jung JU; Choi YK
Cell Rep; 2023 Sep; 42(9):113077. PubMed ID: 37676771
[TBL] [Abstract][Full Text] [Related]
9. Fidelity of Ribonucleotide Incorporation by the SARS-CoV-2 Replication Complex.
Yin X; Popa H; Stapon A; Bouda E; Garcia-Diaz M
J Mol Biol; 2023 Mar; 435(5):167973. PubMed ID: 36690070
[TBL] [Abstract][Full Text] [Related]
10. The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent.
te Velthuis AJ; Arnold JJ; Cameron CE; van den Worm SH; Snijder EJ
Nucleic Acids Res; 2010 Jan; 38(1):203-14. PubMed ID: 19875418
[TBL] [Abstract][Full Text] [Related]
11. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase.
Bertolin AP; Weissmann F; Zeng J; Posse V; Milligan JC; Canal B; Ulferts R; Wu M; Drury LS; Howell M; Beale R; Diffley JFX
Biochem J; 2021 Jul; 478(13):2425-2443. PubMed ID: 34198323
[TBL] [Abstract][Full Text] [Related]
12. Effects of natural polymorphisms in SARS-CoV-2 RNA-dependent RNA polymerase on its activity and sensitivity to inhibitors in vitro.
Miropolskaya N; Kozlov M; Petushkov I; Prostova M; Pupov D; Esyunina D; Kochetkov S; Kulbachinskiy A
Biochimie; 2023 Mar; 206():81-88. PubMed ID: 36252889
[TBL] [Abstract][Full Text] [Related]
13. RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target.
Wang Y; Anirudhan V; Du R; Cui Q; Rong L
J Med Virol; 2021 Jan; 93(1):300-310. PubMed ID: 32633831
[TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates.
Ahn DG; Choi JK; Taylor DR; Oh JW
Arch Virol; 2012 Nov; 157(11):2095-104. PubMed ID: 22791111
[TBL] [Abstract][Full Text] [Related]
15. Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against
Naidu SAG; Mustafa G; Clemens RA; Naidu AS
J Diet Suppl; 2023; 20(2):254-283. PubMed ID: 34850656
[TBL] [Abstract][Full Text] [Related]
16. The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8.
Fan L; Zhou Y; Wei X; Feng W; Guo H; Li Y; Gao X; Zhou J; Wen Y; Wu Y; Shen X; Liu L; Xu G; Zhang Z
mBio; 2024 Feb; 15(2):e0232023. PubMed ID: 38275298
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of a new monoclonal antibody against SARS-CoV-2 NSP12 (RdRp).
Meng W; Guo S; Cao S; Shuda M; Robinson-McCarthy LR; McCarthy KR; Shuda Y; Paniz Mondolfi AE; Bryce C; Grimes Z; Sordillo EM; Cordon-Cardo C; Li P; Zhang H; Perlman S; Guo H; Gao SJ; Chang Y; Moore PS
J Med Virol; 2023 Jan; 95(1):e28246. PubMed ID: 36271490
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
Wang W; Zhou Z; Xiao X; Tian Z; Dong X; Wang C; Li L; Ren L; Lei X; Xiang Z; Wang J
Cell Mol Immunol; 2021 Apr; 18(4):945-953. PubMed ID: 33637958
[TBL] [Abstract][Full Text] [Related]
19. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
20. ATP enhances the error-prone ribonucleotide incorporation by the SARS-CoV-2 RNA polymerase.
Pourfarjam Y; Ma Z; Kim IK
Biochem Biophys Res Commun; 2022 Oct; 625():53-59. PubMed ID: 35947915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
